Revolution Medicines Inc
RVMD
Market Cap$7.27B
Close$
$2.43
93.8% downside
Current Fair Value
93.8% downsideOvervalued by 93.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $7.27 Billion |
|---|---|
| Enterprise Value | $6.87 Billion |
| Dividend Yield | $0 (0%) |
| Earnings per Share | $-3.58 |
| Beta | 1.46 |
| Outstanding Shares | 167,737,672 |
Return
| Return on Equity | - |
|---|---|
| Return on Assets | - |
| Return on Invested Capital | - |
Valuation & Multiples
| P/E Ratio | -10.93 |
|---|---|
| PEG | -24.78 |
| Price to Sales | - |
| Price to Book Ratio | 3.01 |
| Enterprise Value to Revenue | 9252.96 |
| Enterprise Value to EBIT | -10.47 |
| Enterprise Value to Net Income | -13 |
| Total Debt to Enterprise | 0.02 |
| Debt to Equity | 0.06 |
Revenue Sources
No data
Insider Trades
ESG Score
No data
About Revolution Medicines Inc
CEO: Mark Goldsmith